NEW YORK (GenomeWeb) – Waters said today that Brazil's National Health Surveillance Agency (ANVISA) has approved several of the company's liquid chromatography and mass spectrometry systems for in vitro diagnostic use.

The ANVISA approval covers Waters' Acquity UPLC and Acquity UPLC I-Class systems, as well as its Xevo TQD, Xevo TQ-S micro, and Xevo TQ-S mass spectrometers, making them available for clinical use in Brazil.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.